![Vladimir Wolf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vladimir Wolf
No más puestos en curso
Perfil
Vladimir Wolf is the founder of MultiplexDX Inc. which was founded in 2016.
He was the Head of Information Technology at Trophogen, Inc. from 2004 to 2013.
Dr. Wolf holds a doctorate from the University of Bern and an MBA from Julius-Maximilians-Universität Würzburg.
Antiguos cargos conocidos de Vladimir Wolf.
Empresas | Cargo | Fin |
---|---|---|
MultiplexDX Inc.
![]() MultiplexDX Inc. Medical SpecialtiesHealth Technology MultiplexDX sro develops personalized cancer diagnostic tests. It offers RNA sequencing, barcoded pre-adenylated 3-adapters, small RNA library preparation kit, fluorescent in situ hybridization, FullRNAlook, multi-labeled fish probes and fish core services. The company was founded by Pavol Cekan and Vladimir Wolf in 2016 and is headquartered in Presov, Slovakia. | Fundador | - |
Trophogen, Inc.
![]() Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Director Técnico/Científico/I+D | - |
Formación de Vladimir Wolf.
University of Bern | Doctorate Degree |
Julius-Maximilians-Universität Würzburg | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Trophogen, Inc.
![]() Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
MultiplexDX Inc.
![]() MultiplexDX Inc. Medical SpecialtiesHealth Technology MultiplexDX sro develops personalized cancer diagnostic tests. It offers RNA sequencing, barcoded pre-adenylated 3-adapters, small RNA library preparation kit, fluorescent in situ hybridization, FullRNAlook, multi-labeled fish probes and fish core services. The company was founded by Pavol Cekan and Vladimir Wolf in 2016 and is headquartered in Presov, Slovakia. | Health Technology |
- Bolsa de valores
- Insiders
- Vladimir Wolf